ICSA Mentoring Lounge – Data Science in Pharma
Co-sponsored by ICSA and ASA Biopharmaceutical Section
Date: Feb 20, 2026 @2-3pm ET
Mentor panel: Haoda Fu (Amgen), Zhaoling Meng (Sanofi)
Moderator: Yushi Liu (Eli Lilly and Company), Hanfei Xu (Eli Lilly and Company)
Format: One-hour Zoom-based meeting interacting with data science team lead in pharma industry
Target Audience: Students interested in industry or junior statisticians new to industry
Registration link: https://forms.gle/jLcJx64VYCwniucz6
(If you are a member of ASA Biopharm Section, please enter ‘99999999’ as ICSA membership ID in the registration)
About the ICSA Mentoring Lounge
About the Mentors
Dr. Haoda Fu is Head of Exploratory Biostatistics at Amgen and formerly Associate VP and Enterprise Lead for Machine Learning and AI at Eli Lilly. A Fellow of the ASA and IMS, he also serves as an adjunct professor at UNC Chapel Hill and Indiana University. Since earning his Ph.D. from UW–Madison, he has published 100+ papers across Bayesian methods, survival and joint modeling, personalized medicine, and more, with recent emphasis on machine learning and AI. His work appears in top journals such as JASA, JRSS-B, and Biometrika. He frequently teaches ML/AI at major conferences and has held leadership roles in statistical organizations, including service as a JASA associate editor and on the COPSS Snedecor Awards committee.
Dr. Zhaoling Meng is Associate VP, Global Head of Clinical Statistical Modeling in Evidence Generation and Decision Science, sanofi R&D. With 25+ years of experience in Pharma, she built and leads a global team to support and promote modeling & simulation (M&S) and quantitative decision making across drug development stages and various disease areas. Her research interests include development scenario and design decision via competitive landscape modeling, real world data use in informing clinical studies, clinical prediction modeling to trial optimization, and AI/ML method in clinical applications. Prior to sanofi, she also worked at Bill and Melinda Gates Medical Research Institute, Merck, Pfizer and GSK.